Cholinergic Modulation of Binocular Vision.


Journal

The Journal of neuroscience : the official journal of the Society for Neuroscience
ISSN: 1529-2401
Titre abrégé: J Neurosci
Pays: United States
ID NLM: 8102140

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 14 10 2019
revised: 12 05 2020
accepted: 14 05 2020
pubmed: 28 5 2020
medline: 24 11 2020
entrez: 28 5 2020
Statut: ppublish

Résumé

The endogenous neurotransmitter acetylcholine (ACh) is known to affect the excitatory/inhibitory (E/I) balance of primate visual cortex, enhancing feedforward thalamocortical gain while suppressing corticocortical synapses. Recent advances in the study of the human visual system suggest that ACh is a likely component underlying interocular interactions. However, our understanding of its precise role in binocular processes is currently lacking. Here we use binocular rivalry as a probe of interocular dynamics to determine ACh's effects, via the acetylcholinesterase inhibitor (AChEI) donepezil, on the binocular visual system. A total of 23 subjects (13 male) completed two crossover experimental sessions where binocular rivalry measurements were obtained before and after taking either donepezil (5 mg) or a placebo (lactose) pill. We report that enhanced cholinergic potentiation attenuates perceptual suppression during binocular rivalry, reducing the overall rate of interocular competition while enhancing the visibility of superimposition mixed percepts. Considering recent evidence that perceptual suppression during binocular rivalry is causally modulated by the inhibitory neurotransmitter GABA, our results suggest that cholinergic activity counteracts the effect of GABA with regards to interocular dynamics and may modulate the inhibitory drive within the visual cortex.

Identifiants

pubmed: 32457075
pii: JNEUROSCI.2484-19.2020
doi: 10.1523/JNEUROSCI.2484-19.2020
pmc: PMC7329301
doi:

Substances chimiques

Cholinergic Agents 0
Cholinesterase Inhibitors 0
gamma-Aminobutyric Acid 56-12-2
Donepezil 8SSC91326P
Acetylcholine N9YNS0M02X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5208-5213

Subventions

Organisme : CIHR
ID : 148579
Pays : Canada
Organisme : CIHR
ID : MOP-111003
Pays : Canada

Informations de copyright

Copyright © 2020 the authors.

Références

Spat Vis. 1997;10(4):443-6
pubmed: 9176954
Curr Biol. 2010 Oct 12;20(19):1723-8
pubmed: 20850321
J Neurosci. 2017 Apr 19;37(16):4405-4415
pubmed: 28336568
Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):1039-50
pubmed: 24785550
Curr Biol. 2013 May 6;23(9):823-7
pubmed: 23602476
J Comp Neurol. 2019 Feb 15;527(3):738-750
pubmed: 30520037
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8337-44
pubmed: 23610414
Front Comput Neurosci. 2013 May 29;7:66
pubmed: 23755006
Curr Biol. 2016 Jan 11;26(1):80-5
pubmed: 26711497
Spat Vis. 1997;10(4):433-6
pubmed: 9176952
J Neurophysiol. 2012 Oct;108(7):1907-23
pubmed: 22786955
Front Neurosci. 2019 Jan 31;13:22
pubmed: 30766471
Neuron. 2008 Dec 10;60(5):904-14
pubmed: 19081383
Curr Biol. 2018 Dec 17;28(24):R1406-R1413
pubmed: 30562537
J Vis. 2019 May 1;19(5):23
pubmed: 31136647
Curr Biol. 2010 Aug 24;20(16):1464-9
pubmed: 20674360
Vision Res. 2018 Jan;142:40-51
pubmed: 29102622
Front Syst Neurosci. 2014 Sep 18;8:172
pubmed: 25278848
Percept Psychophys. 1980 Jun;27(6):550-6
pubmed: 7393703
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14499-503
pubmed: 14612564
Br J Clin Pharmacol. 1998 Nov;46 Suppl 1:7-12
pubmed: 9839759
Trends Cogn Sci. 2006 Nov;10(11):502-11
pubmed: 16997612
Front Hum Neurosci. 2017 Mar 21;11:128
pubmed: 28377707
PLoS Comput Biol. 2013;9(3):e1002991
pubmed: 23555225
J Neurosci. 2013 Oct 23;33(43):16983-91
pubmed: 24155303
J Neurosci. 2019 Oct 16;39(42):8398-8407
pubmed: 31451579
Front Neural Circuits. 2017 Dec 08;11:100
pubmed: 29276477

Auteurs

Yasha Sheynin (Y)

McGill Vision Research, McGill University, Montréal, Quebec H3G 1A4, Canada.

Pedro Rosa-Neto (P)

Douglas Mental Health University Institute, McGill University, Montréal, Quebec H4H 1R3, Canada.

Robert F Hess (RF)

McGill Vision Research, McGill University, Montréal, Quebec H3G 1A4, Canada robert.hess@mcgill.ca elvire.vaucher@umontreal.ca.

Elvire Vaucher (E)

Laboratoire de Neurobiologie de la Cognition Visuelle, École d'Optométrie, Université de Montréal, Montréal, Quebec H3T 1P1, Canada robert.hess@mcgill.ca elvire.vaucher@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH